Norovirus, often erroneously called the "stomach flu," sickens an estimated 21 million Americans and 685 million people worldwide every year, and though there is currently no preventive vaccine, a ...

Moderna (MRNA) cut its 2025 forecast by $1 billion Monday, citing weak demand for its newest vaccine as well as slow ... aren't looking strong in the near term. "We are not surprised to see ...

While the U.S. already has vaccines against H5 viruses in its Strategic National Stockpile, they are based on older technology. HealthDay News — The U.S. Department of Health and Human Services (HHS) ...

Moderna’s mRNA-1403 is a messenger RNA-based trivalent vaccine candidate designed to protect against multiple norovirus genotypes. Moderna provided an update on the status of its trial investigating a ...

Norovirus cases are significantly increasing in the US and Canada. Moderna is developing an mRNA-based vaccine, currently in Phase 3 clinical trials, with the potential to be the first approved ...

Moderna plans to advance research on the mRNA vaccine into a phase 3 trial after receiving positive results in earlier phases, which it plans to present at a scientific conference in the near future.

The number of wasted Covid-19 vaccines under the national government’s vaccination program went beyond the “acceptable” ...

The American pharmaceutical company Moderna is developing an mRNA-based vaccine candidate for norovirus, designated as mRNA-1403. This vaccine is designed to protect against multiple norovirus ...

Erica Denhoff / Icon Sportswire via Getty Images Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu. The biotech ...

If you can use AI to make custom vaccines and cures for cancer, that could be a tremendous value to society and Moderna's business. More important in the near term, Moderna announced today that it ...

Moderna’s mRNA-1403 is a messenger RNA-based trivalent vaccine candidate designed to protect against multiple norovirus genotypes. Moderna provided an update on the status of its trial ...

Moderna Receives $590M From HHS to Develop Bird Flu Vaccine By India Edwards HealthDay Reporter TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS ...